# OnCo record idea-fund-shelved-asset-escrow (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-fund-shelved-asset-escrow/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-fund-shelved-asset-escrow" ;
  schema:name "Automatic offer of shelved cancer assets to non-profits after two years"@en ;
  schema:description "When a company stops developing a cancer drug for business rather than safety reasons and leaves it idle for two years, it would be obliged to offer the rights, data package and remaining drug supply to qualified non-profit or academic developers on pre-set terms, keeping the right to resume. This turns the stalled-asset registry's listing into a duty."@en ;
  schema:url <https://onco.cc/ideas/idea-fund-shelved-asset-escrow/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamanetworkopen.2020.33972> ;
  onco:related <https://onco.cc/ideas/idea-fund-stalled-asset-registry/>, <https://onco.cc/ideas/idea-fund-nonprofit-pharma/>, <https://onco.cc/ideas/idea-fund-repurposing-indication-exclusivity/>, <https://onco.cc/drugs/tiragolumab/>, <https://onco.cc/drugs/magrolimab/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-ip-collaboration/>, <https://onco.cc/bottlenecks/b-translational-valley/>, <https://onco.cc/bottlenecks/b-rare-cancers/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-danchev-jama-netw-open/> .
